<p>BEAS-2B cells were pre-treated with either PF956980 (checked bars), PF1367550 (hashed bars) or dexamethasone (10<sup>-6</sup>M white bar) for 1h followed by stimulation with IFNγ (10ng/ml) or IFNγ + TNFα for 6 h. Gene expression of <i>CXCL9</i> (panels a and b), <i>CXCL10</i> (panels c and d) and <i>CXCL11</i> (panels e and f) were quantified by Taqman RT-PCR. Data are presented as fold change form stimulus ± SEM; n = 3 where 1 indicates the level of mRNA induced by IFNγ or IFNγ + TNFα in the absence of inhibitors.</p
<p>Human primary airway epithelial cells were pre-treated for 1h with either 1μM PF956980 (PF956) or...
<p>The inhibitor panel consists of small molecules that target the IKK2 (TPCA-1) and TBK1 (BX795, MR...
<p>(<b>a</b>) Sigmoidal dose-response curve showing viability of Ba/F3-mock growing with IL-3 (IC<su...
<p>BEAS-2B cells were pre-treated and incubated for 1h with either PF956980 (○), PF1367550 (●), or d...
<p>BEAS-2B cells were pre-treated with either PF956980 (PF956) or PF1367550 (PF136) for 1h followed ...
<p>Human primary airway epithelial cells were pre-treated for 1h with either PF956980 (○), PF1367550...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>(a) Small molecules reported to inhibit the IKK2 (TPCA-1) and TBK1 (BX795, MRT6884, MRT6707) comp...
<p>BEAS-2B cells were pre-treated for 1h in the presence of either PF956980 or PF1367550 prior to st...
<p>Jurkat T cells (A) or TL-1 cells (B) were treated with 10 ng/mL IFN-γ or water (vehicle control) ...
<p>A, CXCL10 secretion, virtually absent in control, was significantly increased by 24γ (1000 U/ml) ...
<p>BMMΦs were treated with IFNβ (500 U/ml) for 20 min or left untreated. Whole cell extracts were us...
<p><b>(A)</b> R4-GFP and S3-GFP cells treated with IFN-α (1000 I.U/ml) or IFN-λ (100 ng/ml) for 5, 1...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p><b>A.</b> Effect of JAK-STAT inhibitor on the anti-HIV action of IFN-λ3. Macrophages were infecte...
<p>Human primary airway epithelial cells were pre-treated for 1h with either 1μM PF956980 (PF956) or...
<p>The inhibitor panel consists of small molecules that target the IKK2 (TPCA-1) and TBK1 (BX795, MR...
<p>(<b>a</b>) Sigmoidal dose-response curve showing viability of Ba/F3-mock growing with IL-3 (IC<su...
<p>BEAS-2B cells were pre-treated and incubated for 1h with either PF956980 (○), PF1367550 (●), or d...
<p>BEAS-2B cells were pre-treated with either PF956980 (PF956) or PF1367550 (PF136) for 1h followed ...
<p>Human primary airway epithelial cells were pre-treated for 1h with either PF956980 (○), PF1367550...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>(a) Small molecules reported to inhibit the IKK2 (TPCA-1) and TBK1 (BX795, MRT6884, MRT6707) comp...
<p>BEAS-2B cells were pre-treated for 1h in the presence of either PF956980 or PF1367550 prior to st...
<p>Jurkat T cells (A) or TL-1 cells (B) were treated with 10 ng/mL IFN-γ or water (vehicle control) ...
<p>A, CXCL10 secretion, virtually absent in control, was significantly increased by 24γ (1000 U/ml) ...
<p>BMMΦs were treated with IFNβ (500 U/ml) for 20 min or left untreated. Whole cell extracts were us...
<p><b>(A)</b> R4-GFP and S3-GFP cells treated with IFN-α (1000 I.U/ml) or IFN-λ (100 ng/ml) for 5, 1...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p><b>A.</b> Effect of JAK-STAT inhibitor on the anti-HIV action of IFN-λ3. Macrophages were infecte...
<p>Human primary airway epithelial cells were pre-treated for 1h with either 1μM PF956980 (PF956) or...
<p>The inhibitor panel consists of small molecules that target the IKK2 (TPCA-1) and TBK1 (BX795, MR...
<p>(<b>a</b>) Sigmoidal dose-response curve showing viability of Ba/F3-mock growing with IL-3 (IC<su...